Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Innovative Pharmaceutical Biotech ( (HK:0399) ) just unveiled an announcement.
Innovative Pharmaceutical Biotech Limited announced the lapse of its placing agreement with CNI Securities Group for 145 million new shares due to unmet conditions by the deadline. The company assured stakeholders that this development will not adversely affect its current operations or financial standing.
More about Innovative Pharmaceutical Biotech
Innovative Pharmaceutical Biotech Limited is a company incorporated in the Cayman Islands and continued in Bermuda, operating in the pharmaceutical and biotechnology industry. It focuses on developing innovative medical solutions and has a presence in the Hong Kong stock market under the stock code 399.
Average Trading Volume: 23,258,033
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.11B
See more data about 0399 stock on TipRanks’ Stock Analysis page.